Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BONADEA PLUS versus ethinylestradiol + levonorgestrel for ovulation inhibition and metabolic/hemostatic effects
2012-000041-12Phase 2Completed
- Sponsor
- Zentiva
- Start
- Mar 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of dienogest + ethinyl estradiol and ethinylestradiol + levonorgestrel in contraception (2 arms), sponsored by Zentiva. Primary endpoints: Ovulation inhibition, Metabolic parameters and 1 more. Started Mar 2012; status: completed.
02
Drugs
dienogest + ethinyl estradiolethinylestradiol + levonorgestrel
03
Conditions
contraception
Beyond the preview
Go deeper on 2012-000041-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-000041-12.